Sam Altman, the CEO of OpenAI, is backing a groundbreaking initiative aimed at extending human lifespan by a decade through ...

The Pulitzer Prize winner and Tony nominee started out with Will Eisner, and his work appeared in The Village Voice for ...

Trump trotted out Masa’s line about 50,000 new jobs and $50 billion of investment in the U.S. Masa beamed into the TV cameras ...

President Donald Trump is remaking the traditional boundaries of Washington, asserting unprecedented executive power and ...

Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

Sam Altman, the CEO of OpenAI, has announced a shift in his previously critical perspective on President Donald Trump.

OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...

Since then, Musk hasn’t hidden his anger with Altman and OpenAI. He’s currently suing the company over its decision to become ...

Altman and Musk were OpenAI’s founding co-chairs in 2015, but their relationship has devolved into name-calling and lawsuits.

Earlier this week, OpenAI CEO Sam Altman declared the company’s newest reasoning model, o3, ready for public consumption after it passed its external safety testing and announced that it would ...

Elon Musk and Sam Altman publicly dispute the feasibility of 'Stargate,' a $500 billion AI infrastructure project in the US. Musk claims the necessary capital isn't available, while Altman defends ...